Van den Broecke Astrid, Van Coile Laura, Decruyenaere Alexander, Colpaert Kirsten, Benoit Dominique, Van Vlierberghe Hans, Decruyenaere Johan
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Department of Intensive Care Medicine, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.
Ann Intensive Care. 2018 Jan 30;8(1):15. doi: 10.1186/s13613-018-0356-z.
Hypoxic hepatitis (HH) is a type of acute hepatic injury that is histologically characterized by centrilobular liver cell necrosis and that is caused by insufficient oxygen delivery to the hepatocytes. Typical for HH is the sudden and significant increase of aspartate aminotransferase (AST) in response to cardiac, circulatory or respiratory failure. The aim of this study is to investigate its epidemiology, causes, evolution and outcome.
The screened population consisted of all adults admitted to the intensive care unit (ICU) at the Ghent University Hospital between January 1, 2007 and September 21, 2015. HH was defined as peak AST > 5 times the upper limit of normal (ULN) after exclusion of other causes of liver injury. Thirty-five variables were retrospectively collected and used in descriptive analysis, time series plots and Kaplan-Meier survival curves with multi-group log-rank tests.
HH was observed in 4.0% of the ICU admissions at our center. The study cohort comprised 1116 patients. Causes of HH were cardiac failure (49.1%), septic shock (29.8%), hypovolemic shock (9.4%), acute respiratory failure (6.4%), acute on chronic respiratory failure (3.3%), pulmonary embolism (1.4%) and hyperthermia (0.5%). The 28-day mortality associated with HH was 45.0%. Mortality rates differed significantly (P = 0.007) among the causes, ranging from 33.3% in the hyperthermia subgroup to 52.9 and 56.2% in the septic shock and pulmonary embolism subgroups, respectively. The magnitude of AST increase was also significantly correlated (P < 0.001) with mortality: 33.2, 44.4 and 55.4% for peak AST 5-10× ULN, 10-20× ULN and > 20× ULN, respectively.
This study surpasses by far the largest cohort of critically ill patients with HH. HH is more common than previously thought with an ICU incidence of 4.0%, and it is associated with a high all-cause mortality of 45.0% at 28 days. The main causes of HH are cardiac failure and septic shock, which include more than 3/4 of all episodes. Clinicians should search actively for any underlying hemodynamic or respiratory instability even in patients with moderately increased AST levels.
缺氧性肝炎(HH)是一种急性肝损伤,其组织学特征为小叶中心肝细胞坏死,由肝细胞氧输送不足引起。HH的典型表现是在发生心脏、循环或呼吸衰竭时天冬氨酸转氨酶(AST)突然显著升高。本研究的目的是调查其流行病学、病因、演变及转归。
筛查人群包括2007年1月1日至2015年9月21日期间入住根特大学医院重症监护病房(ICU)的所有成年人。HH定义为在排除其他肝损伤原因后AST峰值>正常上限(ULN)的5倍。回顾性收集35个变量,并用于描述性分析、时间序列图以及带有多组对数秩检验的Kaplan-Meier生存曲线分析。
在我们中心,HH在4.0%的ICU入院患者中被观察到。研究队列包括111名患者。HH的病因有心力衰竭(49.1%)、感染性休克(29.8%)、低血容量性休克(9.4%)、急性呼吸衰竭(6.4%)、慢性呼吸衰竭急性加重(3.3%)、肺栓塞(1.4%)和高热(0.5%)。与HH相关的28天死亡率为45.0%。不同病因的死亡率差异显著(P = 0.007),范围从高热亚组的33.3%到感染性休克和肺栓塞亚组的52.9%和56.2%。AST升高的幅度也与死亡率显著相关(P < 0.001):AST峰值为5 - 10×ULN、10 - 20×ULN和>20×ULN时,死亡率分别为33.2%、44.4%和55.4%。
本研究远超迄今为止最大队列的HH重症患者。HH比之前认为的更常见,在ICU中的发病率为4.0%,并且在28天时与45.0%的全因高死亡率相关。HH的主要病因是心力衰竭和感染性休克,占所有病例的3/4以上。即使在AST水平中度升高的患者中,临床医生也应积极寻找任何潜在的血流动力学或呼吸不稳定因素。